{"id":"https://openalex.org/W2005809426","doi":"https://doi.org/10.1021/jm901650u","title":"Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates","display_name":"Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-22","ids":{"openalex":"https://openalex.org/W2005809426","doi":"https://doi.org/10.1021/jm901650u","mag":"2005809426","pmid":"https://pubmed.ncbi.nlm.nih.gov/20095622"},"language":"en","primary_location":{"id":"doi:10.1021/jm901650u","doi":"https://doi.org/10.1021/jm901650u","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm901650u","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005809426"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054559326","display_name":"Joseph T. IV Lundquist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Joseph T. Lundquist","raw_affiliation_strings":["Department of Chemical Sciences","Department of Chemical Sciences, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA. lundquj@wyeth.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]},{"raw_affiliation_string":"Department of Chemical Sciences, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA. lundquj@wyeth.com","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109832789","display_name":"Douglas C. Harnish","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Douglas C. Harnish","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018689119","display_name":"Callain Y. Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Callain Y. Kim","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046809742","display_name":"John F. Mehlmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John F. Mehlmann","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111839157","display_name":"Rayomand J. Unwalla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rayomand J. Unwalla","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014874618","display_name":"Kristin M. Phipps","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kristin M. Phipps","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083124630","display_name":"Matthew L. Crawley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew L. Crawley","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045865077","display_name":"Thomas Commons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Commons","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012975912","display_name":"Daniel M. Green","orcid":"https://orcid.org/0000-0002-5156-5410","observed_orcids":["https://orcid.org/0000-0002-5156-5410"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel M. Green","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109953055","display_name":"Weixin Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Weixin Xu","raw_affiliation_strings":["Department of Chemical Sciences, Wyeth Research, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences, Wyeth Research, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074204150","display_name":"Wah-Tung Hum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wah-Tung Hum","raw_affiliation_strings":["Department of Chemical Sciences, Wyeth Research, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences, Wyeth Research, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089228777","display_name":"Julius E. Eta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julius E. Eta","raw_affiliation_strings":["Drug Safety and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030912883","display_name":"Irene B. Feingold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Irene Feingold","raw_affiliation_strings":["Drug Safety and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058817809","display_name":"Vikram S. Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vikram Patel","raw_affiliation_strings":["Drug Safety and Metabolism"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety and Metabolism","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055793178","display_name":"Mark J. Evans","orcid":"https://orcid.org/0009-0002-5111-6313","observed_orcids":["https://orcid.org/0009-0002-5111-6313"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark J. Evans","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112597432","display_name":"KehDih Lai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"KehDih Lai","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024896000","display_name":"Lisa Borges-Marcucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa Borges-Marcucci","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054519670","display_name":"Paige E. Mahaney","orcid":"https://orcid.org/0009-0002-2228-8888","observed_orcids":["https://orcid.org/0009-0002-2228-8888"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paige E. Mahaney","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030120054","display_name":"Jay E. Wrobel","orcid":"https://orcid.org/0000-0002-7410-5134","observed_orcids":["https://orcid.org/0000-0002-7410-5134"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jay E. Wrobel","raw_affiliation_strings":["Department of Chemical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Sciences","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054559326","https://openalex.org/A5109832789"],"corresponding_institution_ids":["https://openalex.org/I4403928396"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.3995,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88013468,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"53","issue":"4","first_page":"1774","last_page":"1787"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.5570999979972839,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.5570999979972839,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.18410000205039978,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.03799999877810478,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/farnesoid-x-receptor-agonist","display_name":"farnesoid X receptor agonist","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7200000286102295},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.7120000123977661},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8119999766349792},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.7390000224113464},{"id":"https://openalex.org/keywords/vldl-cholesterol","display_name":"VLDL cholesterol","score":0.878000020980835},{"id":"https://openalex.org/keywords/ldl-receptor-knockout-mice","display_name":"LDL receptor knockout mice","score":0.8090000152587891},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.8659999966621399},{"id":"https://openalex.org/keywords/structure-activity-optimization","display_name":"structure-activity optimization","score":0.6460000276565552},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C203862802","wikidata":"https://www.wikidata.org/wiki/Q14905041","display_name":"Farnesoid X receptor","level":5,"score":0.9609090089797974},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9029338955879211},{"id":"https://openalex.org/C143724316","wikidata":"https://www.wikidata.org/wiki/Q312468","display_name":"Series (stratigraphy)","level":2,"score":0.5615628361701965},{"id":"https://openalex.org/C123079801","wikidata":"https://www.wikidata.org/wiki/Q750240","display_name":"Modulation (music)","level":2,"score":0.4872071146965027},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4621347486972809},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.4593544006347656},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35572898387908936},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33404484391212463},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07964181900024414},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.07582828402519226},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C107038049","wikidata":"https://www.wikidata.org/wiki/Q35986","display_name":"Aesthetics","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000099150","descriptor_name":"Receptor, Farnesoid X-Activated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008253","descriptor_name":"Macaca mulatta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011973","descriptor_name":"Receptors, LDL","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm901650u","doi":"https://doi.org/10.1021/jm901650u","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm901650u","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:20095622","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20095622","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1832709945","https://openalex.org/W1976621716","https://openalex.org/W1992439813","https://openalex.org/W1997864253","https://openalex.org/W2005456200","https://openalex.org/W2016716035","https://openalex.org/W2017184248","https://openalex.org/W2040076362","https://openalex.org/W2045845834","https://openalex.org/W2046976578","https://openalex.org/W2049515100","https://openalex.org/W2051040521","https://openalex.org/W2053581007","https://openalex.org/W2065197818","https://openalex.org/W2079080809","https://openalex.org/W2082752454","https://openalex.org/W2094723419","https://openalex.org/W2100125821","https://openalex.org/W2102459969","https://openalex.org/W2106169706","https://openalex.org/W2109221130","https://openalex.org/W2117639596","https://openalex.org/W2128742947","https://openalex.org/W2171398834","https://openalex.org/W2341281514","https://openalex.org/W2951907718"],"related_works":["https://openalex.org/W4238021549","https://openalex.org/W2202758778","https://openalex.org/W2082752454","https://openalex.org/W2034530884","https://openalex.org/W2017257127","https://openalex.org/W3091843158","https://openalex.org/W2097345485","https://openalex.org/W2109221130","https://openalex.org/W2126082120","https://openalex.org/W4308388856"],"abstract_inverted_index":{"In":[0,68],"an":[1],"effort":[2],"to":[3,45,75,146],"develop":[4],"orally":[5],"active":[6],"farnesoid":[7],"X":[8],"receptor":[9,97],"(FXR)":[10],"agonists,":[11],"a":[12,84,156],"series":[13],"of":[14,26,38,78,151,166],"tetrahydroazepinoindoles":[15],"with":[16,40],"appended":[17],"solubilizing":[18,42],"amine":[19],"functionalities":[20,43],"were":[21,56,133],"synthesized.":[22],"The":[23],"crystal":[24],"structure":[25],"the":[27,36,47,51,76,144,148,163],"previously":[28],"disclosed":[29],"FXR":[30,157],"agonist,":[31],"1":[32],"(FXR-450),":[33],"aided":[34],"in":[35,58,62,71,83,93,105,116,159,168,171],"design":[37],"compounds":[39,55],"tethered":[41],"designed":[44],"reach":[46],"solvent":[48],"cavity":[49],"around":[50],"hFXR":[52],"receptor.":[53],"These":[54,141],"soluble":[57],"0.5%":[59],"methylcellulose/2%":[60],"Tween-80":[61],"water":[63],"(MC/T)":[64],"for":[65,109],"oral":[66],"administration.":[67],"vitro":[69],"and":[70,80,125,136,161],"vivo":[72],"optimization":[73],"led":[74],"identification":[77],"14dd":[79],"14cc,":[81],"which":[82],"dose-dependent":[85],"fashion":[86],"regulated":[87],"low":[88,94,127],"density":[89,95,128],"lipoprotein":[90,96,129],"cholesterol":[91,130],"(LDLc)":[92],"knockout":[98],"(LDLR(-/-))":[99],"mice.":[100],"Compound":[101],"14cc":[102,167],"was":[103,138],"dosed":[104],"female":[106],"rhesus":[107],"monkeys":[108],"4":[110],"weeks":[111],"at":[112],"60":[113],"mg/kg":[114],"daily":[115],"MC/T":[117],"vehicle.":[118],"After":[119],"7":[120],"days,":[121],"triglyceride":[122],"(TG)":[123],"levels":[124,132,154],"very":[126],"(VLDLc)":[131],"significantly":[134],"decreased":[135,139],"LDLc":[137,153],"63%.":[140],"data":[142],"are":[143],"first":[145],"demonstrate":[147],"dramatic":[149],"lowering":[150],"serum":[152],"by":[155],"agonist":[158],"primates":[160],"supports":[162],"potential":[164],"utility":[165],"treating":[169],"dyslipidemia":[170],"humans":[172],"beyond":[173],"just":[174],"TG":[175],"lowering.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005809426","counts_by_year":[{"year":2025,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
